z-logo
Premium
The clinical and economic benefits of school‐based quadrivalent HPV vaccination in Singapore
Author(s) -
Tay Sun Kuie,
Hsu TunYing,
Shcheprov Andrei,
Walia Anuj,
Kulkarni Amit S.
Publication year - 2017
Publication title -
international journal of gynecology and obstetrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.895
H-Index - 97
eISSN - 1879-3479
pISSN - 0020-7292
DOI - 10.1002/ijgo.12126
Subject(s) - medicine , genital warts , vaccination , cervical cancer , cervical intraepithelial neoplasia , incidence (geometry) , regimen , gynecology , demography , pediatrics , cancer , immunology , physics , sociology , optics
Objective To investigate the clinical and economic impacts of school‐based administration of the quadrivalent HPV vaccine. Methods A retrospective health‐economic analysis was conducted using data collected in Singapore between 2004 and 2005. A dynamic transmission model was adapted for universal vaccination that provided 80% coverage among students aged 11–12 years. Strategy 1 involved only girls, with a 5‐year catch‐up vaccination to provide 50% coverage among those aged 13–17 years. Strategy 2 included both girls and boys with no catch‐up vaccination. Outcomes included the predicted incidence of HPV ‐related disease over 100 years. Results Current coverage was assumed to be 5%. Strategy 1 would reduce cervical intraepithelial neoplasia grade 1 ( CIN 1) by 63.8%, cervical intraepithelial neoplasia grade 2–3 ( CIN 2–3) by 62.9%, cervical cancer by 50.9%, and genital warts by 78.0% (female individuals) and 73.6% (male individuals). Strategy 2 would reduce CIN 1 by 64.0%, CIN 2–3 by 63.1%, cervical cancer by 50.7%, and genital warts by 79.9% (female individuals) and 80.1% (male individuals). The incremental cost‐effectiveness ratio was S$12 464 for strategy 1 and $27 837 for Strategy 2. These values decreased to $7477 and $22 574, respectively, if a two‐dose regimen was adapted. Conclusion School‐based quadrivalent HPV vaccination offered clinical and economic benefits, and is cost‐effective in Singapore.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here